Clarification on the potential of subcutaneous ethyol as a radioprotective agent
- PMID: 11230504
- DOI: 10.1200/JCO.2001.19.5.1582
Clarification on the potential of subcutaneous ethyol as a radioprotective agent
Comment on
-
Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.J Clin Oncol. 2000 Jun;18(11):2226-33. doi: 10.1200/JCO.2000.18.11.2226. J Clin Oncol. 2000. PMID: 10829042 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources